Figure 4.

Range of clinical indications investigated in RSV trials and breakdown of the types of participants involved. Each study (including reanalyses) was classified according to its main purpose, such as the treatment or prevention of a particular disease according to the headings shown, or to establish more fundamental characteristics such as pharmacokinetics, ADME, or drug interactions. The studies are further classified according to the participants involved and whether they are healthy volunteers, healthy overweight/obese individuals, or patients with an underlying pathology/disease. Data presented were extracted from all the references cited in Table 1 and Table S1.